TY  - GEN
AU  - Han,Kelong
AU  - Jin,Jin
AU  - Maia,Mauricio
AU  - Lowe,John
AU  - Sersch,Martina A
AU  - Allison,David E
TI  - Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trial
SN  - 1550-7416
PY  - 2015///0512
KW  - Adenocarcinoma
KW  - blood
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bayes Theorem
KW  - Bevacizumab
KW  - Biological Availability
KW  - Capecitabine
KW  - Cisplatin
KW  - Deoxycytidine
KW  - Disease Progression
KW  - Drug Monitoring
KW  - Female
KW  - Fluorouracil
KW  - Gastrectomy
KW  - Humans
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Middle Aged
KW  - Models, Biological
KW  - Stomach Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article
UR  - https://doi.org/10.1208/s12248-014-9631-6
ER  -